Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the older maintenance notices (including Revision: v3.4.1) as part of a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding lapse notice banner was added and the site revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedShow glossary option added. QC metadata updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous labels 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4', and capitalization adjusted for 'No FEAR Act Data'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedStrovolos is now listed as a study location under Locations, and the Strovolos Locations entry has been removed. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedPublications are now described as auto-filled from PubMed and possibly not about the study. The page revision has been updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.